Animal Toxicity Studies
Animal Toxicity Studies - Related Videos
01:23
Toxicity Testing in Animals
0 Views •
2026
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
26:43
Computer-Generated Animal Model Stimuli
0 Views •
Cited by 8 •
2007
Computer-generated stimuli using the Jacky dragon as a model.
07:21
Automated Interactive Video Playback for Studies of Animal Communication
0 Views •
Cited by 23 •
2011
Video playback is a widely used technique in animal behavior. We created and evaluated a program that applies rules-based, interactive playback of 3-D computer animations in response to real-time, automated data on subject behavior.
08:53
The Arteriovenous (AV) Loop in a Small Animal Model to Study Angiogenesis and Vascularized Tissue Engineering
0 Views •
Cited by 38 •
2016
We describe a microsurgical approach for the generation of an arteriovenous (AV) loop as a model for analyzing vascularization in vivo in an isolated and well-characterized environment. This model is not only useful for the investigation of angiogenesis, but is also optimally suited for engineering axially vascularized and transplantable tissues.
12:53
Collection and Processing of Lymph Nodes from Large Animals for RNA Analysis: Preparing for Lymph Node Transcriptomic Studies of Large Animal Species
0 Views •
Cited by 1 •
2018
This protocol provides an overview of procedures for the isolation of RNA for the transcriptomic profiling of lymph node tissues from large animals, including steps in the identification and excision of lymph nodes from livestock and wildlife, sampling approaches to provide consistency across multiple animals, and considerations plus representative results for the post-collection preservation and processing for RNA analysis.
FAQs
Animal toxicity studies become more informative when findings are related to administered dose. Researchers compare clinical signs, body changes, clinical pathology findings, organ examination results, and histopathology across dose levels. This pattern can show whether harmful effects are dose-related and help identify target organs, supporting compound selection, study design, and decisions aimed at developing safer medicines.
Route and observation period are important because they frame the risk being evaluated. Administering defined doses through a relevant route allows researchers to examine exposure in a context appropriate to the test substance, while monitoring over a specified period captures changes that may emerge during the study. These choices strengthen interpretation of clinical and organ-level findings.
Considering acute and repeated administration helps characterize toxicity under different dosing patterns. A study may examine harmful effects associated with a shorter exposure or evaluate changes that develop when administration occurs repeatedly over a specified period. Comparing these findings supports a broader assessment of dose-related effects, potential target-organ toxicity, and exposure limits relevant to pharmacological development.
Evaluation combines several levels of evidence rather than relying on a single observation. Researchers monitor clinical signs and body changes, assess clinical pathology, examine organs, and analyze tissues through histopathology. Together, these findings can connect visible or physiological changes with organ and tissue effects, improving interpretation of toxicity and helping identify patterns associated with administered dose.
In pharmacology, toxicity findings inform compound selection and subsequent study design. They help characterize dose-response relationships, target-organ toxicity, exposure limits, and risks linked to acute or repeated administration. Researchers can then weigh potential therapeutic benefit against observed toxicity, while the evidence also contributes to regulatory decisions and the development of safer medicines.
Results can support decisions about whether a compound should continue in development, how later studies should be designed, and which safety issues require attention. Evidence on harmful effects, dose relationships, target organs, and exposure limits helps characterize potential risk before human use. These findings also provide information relevant to regulatory review and therapeutic-benefit versus toxicity assessment.